Susquehanna International Group, LLP Akouos, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$2.6 - $5.16 $200,200 - $397,320
-77,000 Reduced 71.43%
30,800 $208,000
Q2 2022

Aug 15, 2022
BUY
$2.46 - $5.2 $47,478 - $100,360
19,300 Added 21.81%
107,800 $506,000
Q1 2022

May 16, 2022
BUY
$4.16 - $9.08 $178,048 - $388,624
42,800 Added 93.65%
88,500 $420,000
Q4 2021

Feb 14, 2022
BUY
$7.65 - $11.38 $349,605 - $520,066
45,700 New
45,700 $388,000

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email